Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-316.44	-49.51	-11.89
Graham Fair Price	41.23	0.29	0.20
PEG	-93.51	-0.01	0.22
Price/Book	-6.54	0.24	0.25
Price/Cash Flow	93.73	-33.48	-533.68
Prices/Earnings	53.27	-1.41	-3.02
Price/Sales	-53.27	8.18	17.50
Price/FCF	93.73	-33.48	-533.68
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-61.99	0.38	1.00
Operating Margin	0.00	-0.34	-0.34
ROA	-100.00	-0.03	-0.01
ROE	-0.02	-0.04	-100.00
ROIC	< 0.005	< 0.005	-86.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.39	-1.00	159.18
EPS QOQ	0.14	-1.00	620.00
FCF QOQ	0.98	-13.90	1312.41
Revenue QOQ	-0.53	1.00	88.11
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	4116.55	100.00
Days Sales Outstanding (DSO)	0.00	110.95	100.00
Inventory Turnover	0.00	0.02	100.00
Debt/Capitalization	0.00	0.04	100.00
Quick Ratio	2.86	0.59	-79.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.30	0.30	-0.14
Cash	0.02	0.07	279.37
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	-1387.92
Revenue	< 0.005	< 0.005	99.73
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.86	2.27	-20.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.21	-20.72	391.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating